BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20299826)

  • 21. The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.
    Papadopoulos NG; Philip G; Giezek H; Watkins M; Smugar SS; Polos PG
    J Asthma; 2009 May; 46(4):413-20. PubMed ID: 19484680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Montelukast treatment does not affect peripheral blood neutrophil functions in asthma patients.
    Levy R; Avnun L; Shimonovitz F; Konforty A; Heimer D
    Respiration; 2004; 71(1):37-44. PubMed ID: 14872109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukotriene receptor antagonists (Montelukast) in the treatment of asthma crisis: preliminary results of a double-blind placebo controlled randomized study.
    Ferreira MB; Santos AS; Pregal AL; Michelena T; Alonso E; de Sousa AV; Pereira E; Palma-Carlos AG
    Allerg Immunol (Paris); 2001 Oct; 33(8):315-8. PubMed ID: 11763721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exhaled nitric oxide levels in patients with atopic cough and cough variant asthma.
    Fujimura M; Ohkura N; Abo M; Furusho S; Waseda Y; Ichikawa Y; Hara J
    Respirology; 2008 May; 13(3):359-64. PubMed ID: 18399857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
    Ilowite J; Webb R; Friedman B; Kerwin E; Bird SR; Hustad CM; Edelman JM
    Ann Allergy Asthma Immunol; 2004 Jun; 92(6):641-8. PubMed ID: 15237766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
    Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
    Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Real-world" effectiveness of daily controller medicine in children with mild persistent asthma.
    Bukstein DA; Luskin AT; Bernstein A
    Ann Allergy Asthma Immunol; 2003 May; 90(5):543-9. PubMed ID: 12775136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukotriene receptor antagonists: a good choice in the treatment of premenstrual asthma?
    Pasaoglu G; Mungan D; Abadoglu O; Misirligil Z
    J Asthma; 2008 Mar; 45(2):95-9. PubMed ID: 18350399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study.
    Garcia Garcia ML; Wahn U; Gilles L; Swern A; Tozzi CA; Polos P
    Pediatrics; 2005 Aug; 116(2):360-9. PubMed ID: 16061590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma.
    Yi F; Zhan C; Liu B; Li H; Zhou J; Tang J; Peng W; Luo W; Chen Q; Lai K
    Respir Res; 2022 Oct; 23(1):279. PubMed ID: 36217131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can montelukast shorten prednisolone therapy in children with mild to moderate acute asthma? A randomized controlled trial.
    Schuh S; Willan AR; Stephens D; Dick PT; Coates A
    J Pediatr; 2009 Dec; 155(6):795-800. PubMed ID: 19656525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.
    Busse W; Raphael GD; Galant S; Kalberg C; Goode-Sellers S; Srebro S; Edwards L; Rickard K;
    J Allergy Clin Immunol; 2001 Mar; 107(3):461-8. PubMed ID: 11240946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
    Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
    Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of montelukast sodium on serum arginase levels in patients with seasonal allergic rhinitis.
    Yasar H; Kiran B; Cagatay T; Ozkul H; Icten S
    Am J Rhinol Allergy; 2011; 25(4):e153-5. PubMed ID: 21439134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease.
    Ingelsson E; Yin L; Bäck M
    J Allergy Clin Immunol; 2012 Mar; 129(3):702-707.e2. PubMed ID: 22244598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma.
    Kubavat AH; Khippal N; Tak S; Rijhwani P; Bhargava S; Patel T; Shah N; Kshatriya RR; Mittal R
    Am J Ther; 2013; 20(2):154-62. PubMed ID: 22926233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparable effect of a leukotriene receptor antagonist and long-acting beta₂-adrenergic agonist in cough variant asthma.
    Tamaoki J; Yokohori N; Tagaya E; Kirishi S; Miyamoto Y; Ochiai K; Kondo M; Nagai A
    Allergy Asthma Proc; 2010; 31(5):78-84. PubMed ID: 20929598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of efficiency and safety of combined montelukast sodium and budesonide in children with cough variant asthma: A protocol for systematic review and meta-analysis.
    Tang Q; Lei H; You J; Wang J; Cao J
    Medicine (Baltimore); 2021 Jun; 100(25):e26416. PubMed ID: 34160429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.
    Noonan MJ; Chervinsky P; Brandon M; Zhang J; Kundu S; McBurney J; Reiss TF
    Eur Respir J; 1998 Jun; 11(6):1232-9. PubMed ID: 9657560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.